Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
Sára Bech(University of Copenhagen), Kristian Winge(Bispebjerg Hospital), Lisette Salvesen(Bispebjerg Hospital), Lars Rosengren(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Henrik L. Jørgensen(Copenhagen University Hospital), Henrik Zetterberg(University of Wisconsin–Madison), Jørgen E. Nielsen, Niels H. H. Heegaard(Statens Serum Institut), Lena E. Hjermind(Rigshospitalet)
Cited by 48
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k